Clinical Trial Update: Quetiapine Augmentation in Severe Obsessive Compulsive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quetiapine augmentation in adults with severe obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Obsessive Compulsive Disorder | Phase 3 | Status: COMPLETED